Abstract
Background Caesarean section is an important obstetric intervention that saves the lives of mother and newborn babies. However, its increase is of global public health concern. Despite tremendous reduction in maternal and newborn morbidity and mortality, Rwanda has shown a very high incidence of CS among mothers in recent years. Therefore, this study investigated the predictors of patient-initiated elective CS in Rwanda.
Methods In this cross-sectional study, we used nationally representative data from Rwanda Demographic and Health Survey 2019/20. A total of 6,167 females were included in this study. Chi-square test was used to test association between the type of caesarean section and demographic characteristics. Both binary and multivariate regression analysis were performed to assess the predictors of elective caesarean section at a p-value ≤ 0.05 and 95% confidence interval. Model fitness was rigorously conducted to ensure validity and reliability of study findings. The data was analysed using STATA version 14 SE.
Results The rate of CS among women who delivered (6,167) in the last five years preceding the survey was 1,015 (16.46%). Among the women who underwent CS, 36.6% opted for elective CS. Our findings showed that women aged 30 – 39 years were more likely to opt for elective CS [aOR: 3.130, 95%CI:1.969 - 4.978] compared to those aged 29 years or below. Women living in rural areas were less likely to opt for elective CS in the binary regression model [cOR: 0.587, 95%CI: 0.448 – 0.768]. Also, mothers who received ANC assistance by nurse/midwife were 40% less likely [aOR: 0.529, 95%CI: 0.349 – 0.803] to undergo elective CS, than those assisted by doctors.
Conclusion The rate of elective CS is very high among mothers in Rwanda. By using the 2019/20 RDHS data, the study found the key predictors behind the high rate of CS in Rwanda. These predictors should be deeply considered in developing comprehensive measures and policies to mitigate the unnecessary CS in Rwanda, which has detrimental impact on maternal and newborn outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Not Applicable
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study used secondary data obtained from the MEASURE DHS programme. Therefore, ethical approval and participant consent were not necessary. However, permission and approval was obtained from the DHS programme to download and use the data from https://www.dhsprogram.com/
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Not Applicable
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Not Applicable
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Not Applicable
Data Availability
The data for this study is available at https://www.dhsprogram.com/data/available-datasets.cfm.
